SMTL ID : 5dfp.1

Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 59U: 6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-{[2-(1-methylpiperidin-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one

59U.1: 21 residues within 4Å: Chain A: I.28, V.36, A.49, I.50, R.51, M.53, I.64, E.67, I.68, M.71, V.94, M.96, E.97, Y.98, L.99, G.102, S.103, D.106, L.148, T.158 Ligands: DMS.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.49, A:R.51, A:I.64, A:L.148 Hydrogen bonds: A:L.99 Salt bridges: A:D.106

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 5 residues within 4Å: Chain A: R.51, E.67, D.159, G.161 Ligands: 59U.1 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:E.67, A:D.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ndubaku, C.O. et al., Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety. Acs Med.Chem.Lett. (2015)

Release Date

2016-01-27

Peptides

Serine/threonine-protein kinase PAK 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PAK 1

Related Entries With Identical Sequence